Vapiprost-impurities | Pharmaffiliates

Vapiprost and its Impurities

Vapiprost events and occlusive vascular disease. Phase III trials were underway in Japan for the treatment of deep vein thrombosis. Reference standards of Vapiprost API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 1 results for Vapiprost Impurities
PA 22 58000

Vapiprost - API Standards

Vapiprost


  • Catalogue No.:PA 22 58000

  • CAS :

    85505-64-2

  • Molecular Formula : C30H39NO4

  • Molecular Weight : 477.63